CareFusion Corp (CFN): Today's Featured Health Care Winner

CareFusion ( CFN) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.8%. By the end of trading, CareFusion rose $0.57 (1.5%) to $39.13 on light volume. Throughout the day, 1,535,848 shares of CareFusion exchanged hands as compared to its average daily volume of 2,180,000 shares. The stock ranged in a price between $38.49-$39.20 after having opened the day at $38.49 as compared to the previous trading day's close of $38.56. Other companies within the Health Care sector that increased today were: ImmunoCellular Therapeutics ( IMUC), up 15.1%, Organovo Holdings ( ONVO), up 13.3%, Ambit Biosciences ( AMBI), up 11.6% and Given Imaging ( GIVN), up 10.3%.

CareFusion Corporation provides various healthcare products and services in the United States and internationally. It operates in two segments, Medical Systems and Procedural Solutions. CareFusion has a market cap of $8.5 billion and is part of the health services industry. Shares are up 34.8% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the negative front, Mast Therapeutics ( MSTX), down 35.9%, Mazor Robotics ( MZOR), down 8.5%, Tranzyme ( TZYM), down 6.9% and BSD Medical Corporation ( BSDM), down 6.8% , were all laggards within the health care sector with Onyx Pharmaceuticals ( ONXX) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Jim Cramer: The S&P 500 Isn’t as Passive as You Might Think

Jim Cramer's 'Mad Money' Recap: This Is One Stupid Market

3 Stocks Reiterated As A Buy: CFN, UTX, WHR

Insider Trading Alert - CFN, VSR And CAVM Traded By Insiders

Jim Cramer on the Stock Market: Spinoffs Are in Vogue